» Articles » PMID: 35601918

A Mathematical Model of Neuroimmune Interactions in Epileptogenesis for Discovering Treatment Strategies

Overview
Journal iScience
Publisher Cell Press
Date 2022 May 23
PMID 35601918
Authors
Affiliations
Soon will be listed here.
Abstract

The development of epilepsy (epileptogenesis) involves a complex interplay of neuronal and immune processes. Here, we present a first-of-its-kind mathematical model to better understand the relationships among these processes. Our model describes the interaction between neuroinflammation, blood-brain barrier disruption, neuronal loss, circuit remodeling, and seizures. Formulated as a system of nonlinear differential equations, the model reproduces the available data from three animal models. The model successfully describes characteristic features of epileptogenesis such as its paradoxically long timescales (up to decades) despite short and transient injuries or the existence of qualitatively different outcomes for varying injury intensity. In line with the concept of degeneracy, our simulations reveal multiple routes toward epilepsy with neuronal loss as a sufficient but non-necessary component. Finally, we show that our model allows for predictions of therapeutic strategies, revealing injury-specific therapeutic targets and optimal time windows for intervention.

Citing Articles

VDAC1 Inhibition Mitigates Inflammatory Status and Oxidative Stress in Epileptic Mice Treated with the Ketogenic Diet.

Luo X, Yue J Neurochem Res. 2025; 50(2):118.

PMID: 40085179 DOI: 10.1007/s11064-025-04366-2.


Degeneracy in epilepsy: multiple routes to hyperexcitable brain circuits and their repair.

Stober T, Batulin D, Triesch J, Narayanan R, Jedlicka P Commun Biol. 2023; 6(1):479.

PMID: 37137938 PMC: 10156698. DOI: 10.1038/s42003-023-04823-0.

References
1.
Polascheck N, Bankstahl M, Loscher W . The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp Neurol. 2010; 224(1):219-33. DOI: 10.1016/j.expneurol.2010.03.014. View

2.
Olsen T . Post-stroke epilepsy. Curr Atheroscler Rep. 2001; 3(4):340-4. DOI: 10.1007/s11883-001-0029-4. View

3.
Loscher W . Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models. Epilepsy Behav. 2015; 49:20-5. DOI: 10.1016/j.yebeh.2015.02.027. View

4.
Gerhauser I, Hansmann F, Ciurkiewicz M, Loscher W, Beineke A . Facets of Theiler's Murine Encephalomyelitis Virus-Induced Diseases: An Update. Int J Mol Sci. 2019; 20(2). PMC: 6358740. DOI: 10.3390/ijms20020448. View

5.
Bertram E . Neuronal circuits in epilepsy: do they matter?. Exp Neurol. 2012; 244:67-74. PMC: 4266595. DOI: 10.1016/j.expneurol.2012.01.028. View